Literature DB >> 16231589

The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.

L Miele1, A Forgione, A P Hernandez, M L Gabrieli, V Vero, P Di Rocco, A V Greco, G Gasbarrini, A Gasbarrini, A Grieco.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a condition of increasing incidence in western Countries seldom associated to other diseases of high prevalence in general population (i.e. diabetes and obesity). NAFLD ranges from simple fatty liver to steatohepatitis (NASH), which may lead to cryptogenic cirrhosis and in some cases hepatocellular carcinoma (HCC). Natural history of NAFLD in humans is poorly understood and progression of liver disease seems to be due to interaction between hosting (i.e. genetic, gut flora, insulin resistance) and environmental factors (social and eating behaviours) that should be responsible of increased oxidative stress within hepatocytes. Even if we need non-invasive markers able to describe the progression of liver disease, only meaning of liver biopsy is useful to characterize the stigmata of worsening such as inflammation and fibrosis.

Entities:  

Mesh:

Year:  2005        PMID: 16231589

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

1.  Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.

Authors:  Shehab M Abd El-Kader; Fadwa M Al-Shreef; Osama H Al-Jiffri
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

Review 2.  Signal transductions and nonalcoholic fatty liver: a mini-review.

Authors:  Lu Zeng; Wai J Tang; Jin J Yin; Bei J Zhou
Journal:  Int J Clin Exp Med       Date:  2014-07-15

3.  A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease.

Authors:  Luca Miele; Valentina Dall'armi; Consuelo Cefalo; Bojan Nedovic; Dario Arzani; Rosarita Amore; Gianlodovico Rapaccini; Antonio Gasbarrini; Walter Ricciardi; Antonio Grieco; Stefania Boccia
Journal:  Genes Nutr       Date:  2014-01-09       Impact factor: 5.523

4.  Methionine deficiency and hepatic injury in a dietary steatohepatitis model.

Authors:  Helieh S Oz; Theresa S Chen; Manuela Neuman
Journal:  Dig Dis Sci       Date:  2007-08-21       Impact factor: 3.199

5.  Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver disease.

Authors:  Rana V Smalling; Don A Delker; Yuxia Zhang; Natalia Nieto; Michael S McGuiness; Shuanghu Liu; Scott L Friedman; Curt H Hagedorn; Li Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-06-27       Impact factor: 4.052

Review 6.  Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.

Authors:  Alessandro Federico; Marcello Dallio; Carmelina Loguercio
Journal:  Molecules       Date:  2017-01-24       Impact factor: 4.411

7.  Sex-associated preventive effects of low-dose aspirin on obesity and non-alcoholic fatty liver disease in mouse offspring with over-nutrition in utero.

Authors:  Yi Zhou; Hui Peng; Zhimin Liu; Ke K Zhang; Chelsea Jendrusch; Madeline Drake; Yi Hao; Linglin Xie
Journal:  Lab Invest       Date:  2018-11-09       Impact factor: 5.662

8.  Maternal diet intervention before pregnancy primes offspring lipid metabolism in liver.

Authors:  Yi Zhou; Hui Peng; Huiting Xu; Jiangyuan Li; Mikhail Golovko; Henghui Cheng; Ernest C Lynch; Lin Liu; Naomi McCauley; Lindsey Kennedy; Gianfranco Alpini; Ke K Zhang; Linglin Xie
Journal:  Lab Invest       Date:  2019-11-20       Impact factor: 5.662

9.  Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity.

Authors:  Praveen Guturu; Andrea Duchini
Journal:  Int J Hepatol       Date:  2012-06-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.